W. J. Meerding

1.2k total citations
13 papers, 904 citations indexed

About

W. J. Meerding is a scholar working on Economics and Econometrics, General Health Professions and Public Health, Environmental and Occupational Health. According to data from OpenAlex, W. J. Meerding has authored 13 papers receiving a total of 904 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Economics and Econometrics, 5 papers in General Health Professions and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in W. J. Meerding's work include Health Systems, Economic Evaluations, Quality of Life (5 papers), Global Health Care Issues (4 papers) and Healthcare Policy and Management (2 papers). W. J. Meerding is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (5 papers), Global Health Care Issues (4 papers) and Healthcare Policy and Management (2 papers). W. J. Meerding collaborates with scholars based in Netherlands, United Kingdom and Sweden. W. J. Meerding's co-authors include Marc Koopmanschap, Johan Polder, Luc Bonneux, P.J. van der Maas, Johan L. Severens, Wilhelmina IJzelenberg, Alex Burdorf, J. P. Mackenbach, Anton E. Kunst and Saakje Mulder and has published in prestigious journals such as Journal of Clinical Epidemiology, British Journal of Cancer and Journal of Epidemiology & Community Health.

In The Last Decade

W. J. Meerding

13 papers receiving 853 citations

Peers

Countries citing papers authored by W. J. Meerding

Since Specialization

Citations

This map shows the geographic impact of W. J. Meerding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. J. Meerding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. J. Meerding more than expected).

Fields of papers citing papers by W. J. Meerding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. J. Meerding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. J. Meerding. The network helps show where W. J. Meerding may publish in the future.

Co-authorship network of co-authors of W. J. Meerding

This figure shows the co-authorship network connecting the top 25 collaborators of W. J. Meerding. A scholar is included among the top collaborators of W. J. Meerding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. J. Meerding. W. J. Meerding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Potential cardiovascular consequences of switching from atorvastatin to generic simvastatin in the Netherlands 2012 ·Netherlands Heart Journal ·Danny Liew, Kate Webb, W. J. Meerding, Erik Buskens, J. Wouter Jukema	5
2	Deriving reference values and utilities for the QoL-AGHDA in adult GHD 2010 ·The European Journal of Health Economics ·Jan J.V. Busschbach, Bruce H. R. Wolffenbuttel, Lieven Annemans, W. J. Meerding, Maria Kołtowska‐Häggström	9
3	Economic costs of health inequalities in the European Union 2010 ·Journal of Epidemiology & Community Health ·J. P. Mackenbach, W. J. Meerding, Anton E. Kunst	112
4	Linguistic validation of the DN4 for use in international studies 2009 ·European Journal of Pain ·Robert van Seventer, C. J. de Vos, W. J. Meerding, I Mear, Martine Le Gal, Didier Bouhassira, (unknown)	69
5	The impact of healthcare costs in the last year of life and in all life years gained on the cost-effectiveness of cancer screening 2009 ·British Journal of Cancer ·Inge M.C.M. de Kok, Johan Polder, J. Dik F. Habbema, (unknown), W. J. Meerding, Matejka Rebolj, Marjolein van Ballegooijen	21
6	Cost Effectiveness of Withdrawal of Fall-Risk-Increasing Drugs in Geriatric Outpatients 2008 ·Drugs & Aging ·Nathalie van der Velde, W. J. Meerding, Caspar W.N. Looman, Huibert A. P. Pols, Tischa J. M. van der Cammen	18
7	Patients’ preferences for osteoporosis drug treatment: a discrete choice experiment 2008 ·Osteoporosis International ·Esther W. de Bekker‐Grob, Marie‐Louise Essink‐Bot, W. J. Meerding, Huibert A. P. Pols, Bart W. Koes, Ewout W. Steyerberg	55
8	Methodological issues in comparing injury incidence across countries 2006 ·International Journal of Injury Control and Safety Promotion ·Ronan A Lyons, Suzanne Polinder, (unknown), Saakje Mulder, W. J. Meerding, Hidde Toet, Ed van Beeck, (unknown)	49
9	Health problems lead to considerable productivity loss at work among workers with high physical load jobs 2005 ·Journal of Clinical Epidemiology ·W. J. Meerding, Wilhelmina IJzelenberg, Marc Koopmanschap, Johan L. Severens, Alex Burdorf	199
10	MC6 PRODISQ A MODULAR QUESTIONNAIRE ON PRODUCTIVITY AND DISEASE FOR ECONOMIC EVALUATION STUDIES IN PATIENT SETTINGS AND ORGANISATIONAL SETTINGS 2004 ·Value in Health ·MA Koopmanschap, W. J. Meerding, Silvia Evers, JL Severens, Alex Burdorf, (unknown)	3
11	Setting priorities in injury prevention: the application of an incidence based cost model 2002 ·Injury Prevention ·Saakje Mulder, W. J. Meerding, Ed F. van Beeck	39
12	Healthcare costs of intellectual disability in the Netherlands: a cost‐of‐illness perspective 2002 ·Journal of Intellectual Disability Research ·Johan Polder, W. J. Meerding, Luc Bonneux, P.J. van der Maas	66
13	Demographic and epidemiological determinants of healthcare costs in Netherlands: cost of illness study 1998 ·BMJ ·W. J. Meerding, Luc Bonneux, Johan Polder, Marc Koopmanschap, P.J. van der Maas	259

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact